Broadcom vs. Taiwan Semiconductor Manufacturing: Which Chip Stock Is a Better Buy in 2026?

TSMC is favored over Broadcom for 2026, based on its central role in manufacturing leading AI chips and stronger FY2025 financial metrics: revenue rose 36% to $122.4B, net income reached $54.4B, and free cash flow was about $32B. Broadcom posted FY2025 revenue growth of 23.9% to $63.9B and $26.9B of free cash flow, but carries roughly $67.1B of debt, customer concentration risk, and dependence on TSMC for advanced-chip manufacturing. The stocks trade at comparable forward P/E multiples of 20.5x for TSMC and 19.8x for Broadcom, while TSMC's low 0.2x debt-to-equity ratio supports continued capacity investment.

Analysis

The investable distinction is not simply foundry versus diversified semiconductor exposure: TSM monetizes aggregate leading-edge wafer demand, while AVGO monetizes a narrower set of high-value design wins and network bottlenecks. As hyperscalers diversify AI compute away from NVDA toward custom ASICs, AVGO can gain content per cluster, but the resulting incremental wafer demand still accrues to TSM. This makes TSM the cleaner basket exposure to AI silicon complexity, including upside from NVDA, AMD, AAPL and AVGO simultaneously.

Near term, the article itself is unlikely to alter positioning; both stocks are already consensus AI beneficiaries and trade at broadly comparable earnings multiples. The more relevant 1-3 month catalyst is evidence that advanced-node capacity remains tight—monthly revenue, customer capex commentary, CoWoS/advanced-packaging lead times, and any upward revision to TSM’s utilization or pricing outlook. A weaker-than-expected hyperscaler capex print would hurt AVGO disproportionately if investors reassess the durability of custom-accelerator programs, while TSM retains broader smartphone/HPC/customer diversification.

The non-obvious risk to TSM is that geographic concentration deserves a persistent valuation discount even if operating execution remains exceptional; a premium multiple requires overseas capacity to become economically meaningful without diluting returns. Conversely, AVGO’s software segment can cushion a semiconductor digestion, but acquisition leverage, integration execution and antitrust remedies could constrain buybacks or multiple expansion. The consensus may underappreciate that custom ASIC adoption is not automatically margin-accretive for AVGO: large customers possess negotiating leverage and can dual-source design components over time, whereas switching foundries at leading edge remains materially harder.

For a 6-18 month horizon, prefer TSM over AVGO as an AI-capex duration trade, but avoid treating it as a geopolitical-free substitute for U.S. semiconductor exposure. The thesis is falsified by sustained deterioration in advanced-node utilization, a material cut to capital-return plans, loss of leading-edge yield leadership, or a cross-strait escalation that impairs production or customer shipment confidence.

Key Decisions for Investors

• Initiate/maintain a 6-18 month long TSM / short AVGO pair, sized beta-neutral: TSM captures broad advanced-node and packaging demand while AVGO carries greater customer-concentration, regulatory and leverage sensitivity. Reassess if AVGO reports semiconductor growth materially above TSM’s advanced-node revenue trajectory for two consecutive quarters.
• Add TSM on post-earnings or macro-driven 8-12% drawdowns rather than chase routine AI-news strength; target a 15-25% relative return versus AVGO over 12 months if foundry pricing/utilization remain firm. Hard risk trigger: a guidance cut tied to advanced-node demand rather than temporary FX or mature-node weakness.
• Use NVDA and AMD earnings as read-through alerts, not direct substitutes: sustained upside in AI shipments is supportive for TSM, but watch gross-margin commentary and supply constraints. Evidence that customers are consuming inventory rather than expanding wafer starts would weaken the TSM thesis within 1-3 months.
• Avoid a standalone AVGO short absent valuation and backlog detail. A better tactical hedge is reducing AVGO exposure ahead of EU antitrust milestones or enterprise-software renewal disclosures; cover the relative short if software bookings accelerate enough to offset any ASIC pricing pressure.